Guy Ofir - Chief Financial Officer, Director at Raphael Pharmaceutical Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer, Director
Issuer Symbol
RAPH on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Guy Ofir since 25 Jan 2025

Holdings reported by Guy Ofir for Raphael Pharmaceutical Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,266,455 $633,228 $0.5000 26 Jul 2022 Direct
Warrants to Purchase Common Stock 1,000,000 05 Dec 2022 Direct Common Stock

Transactions reported by Guy Ofir for Raphael Pharmaceutical Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.